2023-07-19T00:51:11Z
ENA-FIRST-PUBLIC
2023-07-19T00:51:11Z
ENA-LAST-UPDATE
GSM6732460
External Id
SAMN31740238
External Id
2023-07-19T00:51:11Z
INSDC first public
2023-07-19T00:51:11Z
INSDC last update
public
INSDC status
SRS15765575
SRA accession
GSM6732460
Submitter Id
NCBI
broker name
Expanded TIL
cell line
CD4+
cell type
missing
collection_date
human
common name
male
gender
missing
geo_loc_name
10.10%
infusion percent_cd4
89.70%
infusion percent_cd8
7.84E+10
number til_infused
Homo sapiens
organism
112
overall survival_months
0
pfs censor_at_12_months
112
pfs months
PR
response
Homo sapiens
scientific_name
TIL ACT Product
source_name
0
survival censor
TIL ACT Product
tissue
Patient 9 CD4+ [Pt09_CD4 RNA-seq]
title
TIL ACT
treatment
15781
trial